Piramal Enterprises Ltd - PIRAMAL ENTERP. Share Price

Sector: Finance | ISIN: INE140A01024
₹ 819.25 (-1.22%) icon28 May, 2024, 12:00:00 AM

Piramal Enterprises Ltd KEY RATIOS

sector: Finance

  • CMP

    as on 5/28/2024 12:00:00 AM

    ₹ 819.25 -10.15 -1.22
  • Open
  • ₹ 833.5
  • Prev. Close
  • ₹ 829.4
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 833.5
  • Day's Low
  • ₹ 811.05
  • 52 Week's High
  • ₹ 1,139.95
  • 52 Week's Low
  • ₹ 766
  • Book Value
  • ₹ 1,090.77
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 18,405.57
  • P/E
  • 23.1
  • EPS
  • 35.45
  • Divi. Yield
  • 1.22

Piramal Enterprises Ltd Corporate Actions

30 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Jan , 2024

12:00 AM

01 Nov , 2023

12:00 AM

01 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jul , 2023

12:00 AM

12 May , 2023

12:00 AM

AGM

Announcement date: 12 May , 2023

View Details

05 May , 2023

12:00 AM

Dividend

Dividend amount: 31
Announcement date: 05 May , 2023

View Details

No Record Found


Piramal Enterprises Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Piramal Enterprises Ltd SHAREHOLDING SNAPSHOT
29 May , 2024 | 07:19 AM

PROMOTER - TOTAL46.19%

Indian: 46.19%

Foreign: 0%

NON-PROMOTER - TOTAL 53.31%

Institutions: 30.17%

Non-Institutions: 23.15%

CUSTODIES - 0.49%

Custodies: 0.49%

See More Details
ad IconAd Image

Piramal Enterprises Ltd FINANCIALS

View Profit & Loss Graph

Piramal Enterprises Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Piramal Enterprises Ltd

  • Ajay G Piramal
  • Chairman & Exec. Director
  • Swati A Piramal
  • Vice Chairperson
  • Nandini Piramal
  • Executive Director
  • S Rama Dorai
  • Independent Director
  • Anand Piramal
  • Non Executive Director
  • Bipin Singh
  • Company Sec. & Compli. Officer
  • Vijay Shah
  • Non Executive Director
  • Suhail Nathani
  • Independent Director
  • KUNAL BAHL
  • Independent Director
  • Anjali Bansal
  • Independent Director
  • Shikha Sharma
  • Non Executive Director
  • Puneet Yadu Dalmia
  • Independent Director
  • Anita M George
  • Independent Director
  • Rajiv Mehrishi.
  • Independent Director
  • Gautam Doshi
  • Independent Director
  • Asheet Mehta
  • Additional Director

Summary

Piramal Enterprises Limited (PEL), erstwhile Piramal Healthcare Limited, is the flagship company of the Piramal Group, led by Ajay Piramal. Established in the 1980s, the Group is one of Indias powerhouse conglomerates with a track record of establishing successful businesses in varied industries. With a history of successful organic and inorganic growth ventures, the Piramal Group today has a global presence across 30 countries.The Company is a growing, diversified Non-Banking Financial Company (NBFC) with presence in Retail and Wholesale Lending, Alternative funds and Life Insurance businesses. The Company has completed the integration of Dewan Housing Finance Ltd. (DHFL) and is now one of the largest housing finance companies in India.In Pharma, through an end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network to over 100 countries, PEL sells a portfolio of niche differentiated Pharma products and provides an entire pool of Pharma services (including in the areas of injectable, HPAPI etc.). PELs Global Pharma business has a strong product portfolio of niche differentiated branded generic products that are difficult to manufacture, sell or distribute. PELs Contract Development and Manufacturing Organisation (CDMO) services segment offers end-to-end solutions across the drug life cycle through a globally integrated network of facilities. PELs India consumer products division caters to the Indian self-care market. PELs OTC... Read More


Reports by Piramal Enterprises Ltd


Reports by Piramal Enterprises Ltd

Company FAQ

No Record Found